التفاصيل البيبلوغرافية
| العنوان: |
From molecular basis to clinical insights: a challenging future for the vitamin D endocrine system in colorectal cancer. |
| المؤلفون: |
Pereira, Fábio, Fernández‐Barral, Asunción, Larriba, María Jesús, Barbáchano, Antonio, González‐Sancho, José Manuel |
| المصدر: |
FEBS Journal; Jun2024, Vol. 291 Issue 12, p2485-2518, 34p |
| مصطلحات موضوعية: |
VITAMIN D, COLORECTAL cancer, ENDOCRINE system, VITAMIN D deficiency, CHOLECALCIFEROL |
| مستخلص: |
Colorectal cancer (CRC) is one of the most life‐threatening neoplasias in terms of incidence and mortality worldwide. Vitamin D deficiency has been associated with an increased risk of CRC. 1α,25‐Dihydroxyvitamin D3 [1,25(OH)2D3], the most active vitamin D metabolite, is a pleiotropic hormone that, through its binding to a transcription factor of the nuclear receptor superfamily, is a major regulator of the human genome. 1,25(OH)2D3 acts on colon carcinoma and stromal cells and displays tumor protective actions. Here, we review the variety of molecular mechanisms underlying the effects of 1,25(OH)2D3 in CRC, which affect multiple processes that are dysregulated during tumor initiation and progression. Additionally, we discuss the epidemiological data that associate vitamin D deficiency and CRC, and the most relevant randomized controlled trials of vitamin D3 supplementation conducted in both healthy individuals and CRC patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of FEBS Journal is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder